Methylprednisolone taper plus standard pain medicines after ACL repair
Official title: Efficacy of Methylprednisolone for Pain Control After ACL Repair: A Randomized Controlled Trial
Run by St. Louis University · NCT07158476 · Data updated 2026-11-12
We will try adding a methylprednisolone dose-pack to usual pain medicines after ACL repair to see if it lowers pain and reduces opioid use for people aged 13 to 50.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 13 Years to 50 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | St. Louis University Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | October 21, 2025 |
| Main results expected | September 2030 |
| Study ends | September 2031 |
| Registry record updated | October 24, 2025 |
| Trial ID | NCT07158476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 13–50 undergoing primary ACL repair or reconstruction with autograft who can provide informed consent and do not meet the study's exclusion criteria.
✕Probably not a fit
Patients with revision or multi-ligament procedures, chronic opioid use, active infection, significant organ dysfunction, immune suppression, or contraindications to steroids/NSAIDs are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, single-center study enrolls consecutive patients aged 13–50 undergoing primary ACL repair or reconstruction with autograft and follows them for one year. Participants are randomized to a treatment pain regimen that includes a methylprednisolone dose-pack, meloxicam, hydrocodone/acetaminophen, and gabapentin, or to a control regimen of ketorolac, hydrocodone/acetaminophen, and gabapentin. Pain scores and daily opioid pill consumption are reported using the MyCap app the day of surgery and for the first 14–15 postoperative days, and clinic follow-ups occur at 2 weeks, 6 weeks, 12 weeks, and 1 year with collection of PROMs and complications. Demographic, comorbidity, and surgical data are collected from the medical record to compare outcomes between groups.
Why it matters
Potential benefit: If successful, adding a methylprednisolone taper could lower early postoperative pain and reduce opioid consumption and related harms after ACL repair.
How similar studies have gone: Short courses of corticosteroids have reduced pain and opioid use in some surgical settings, but using a methylprednisolone dose-pack after ACL repair in a randomized design is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient undergoing ACL repair or ACL reconstruction with tendon autograft * Age 13-50 years old * Able to provide informed consent or parent/legal guardian is able for minors Exclusion Criteria: * Concurrent and significant injury to other bones or organs (Injury Severity Score of 4 or greater) * Revision ACL reconstruction * Concomitant additional ligament reconstruction or high tibial osteotomy * A history of alcohol abuse, substance abuse or chronic opioid use (filled opioid medication ×2 within 6 months of the surgery) * A history of renal failure (\<60 mL/min/1.73 m2), liver dysfunction (child class, \>B), severe heart disease (NYHA Class 4), diabetes, neurological or psychiatric diseases that may affect pain perception, and pre-existing immune suppression. * A history or active peptic ulcer disease, gastrointestinal bleeding, or current use of anticoagulation. * Patients currently taking oral or injectable glucocorticoids and those who have taken either within 1 month of the procedure. * Patients who are currently pregnant. * Patients who are unable to undergo the multimodal pain standardized protocol including those with comorbidities or medical allergies precluding the use of corticosteroids, gabapentin, hydrocodone, acetaminophen, ketorolac, and/or meloxicam.
Where it's running
-
Saint Louis University
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Scott Kaar, MD — St. Louis University
- Study coordinator: Scott Kaar
- Email: scott.kaar@ssmhealth.com
- Phone: 314-617-3405
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine as add-on for refractory cancer pain in palliative care
This study tests whether adding dexmedetomidine helps improve pain control for adults with cancer in palliative care whose pain remains high despite opioids.
-
Two Ways to Help Pain After Breast Surgery: Education-Based Analgesia vs Standard Care
This trial tests whether teaching patients about pain management and using a multimodal pain plan improves pain control and recovery after breast surgery compared with standard care.
-
Virtual Reality Therapy to Improve Arthroplasty Outcomes
This pilot test checks whether using virtual reality during the perioperative period helps knee or hip replacement patients feel better about their care and recover more easily.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Plyometric training added to standard rehab after ACL reconstruction
This study tests whether adding plyometrics to the usual rehab after ACL reconstruction helps improve leg strength and function in adults aged 18–40.
-
Isokinetic vs Plyometric Training After ACL Reconstruction
This trial tests whether isokinetic or plyometric training, added after standard rehab, best improves strength, function, and patient-reported outcomes in adults 18–40 after ACL reconstruction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.